Immuneering Corp (IMRX) Social Stream



Immuneering Corp (IMRX): $5.00

-0.41 (-7.58%)

POWR Rating

Component Grades

Growth

S

Value

I

Momentum

G

Stability

N

Sentiment

U

Quality

P

Add IMRX to Watchlist
Sign Up

Industry: Biotech


Ranked

of 399

in industry

Immuneering Corp (IMRX) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering Immuneering Corp.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-09 4 $50 $39 $43.666 $7.44 486.91%
2021-12-22 4 $42 $35 $38.666 $7.44 419.7%
2022-01-07 5 $42 $35 $39.25 $7.44 427.55%
2022-03-10 5 $42 $18 $34 $7.44 356.99%
2022-03-27 6 $42 $18 $30.25 $7.44 306.59%

IMRX reports an average of 215.06% for its upside potential over the past 138 days.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2021-11-09 4 50 39 43.666 29.95 45.8%
2021-12-22 5 42 35 38.666 23.03 67.89%
2021-12-22 4 42 35 38.666 23.03 67.89%
2022-01-31 5 42 18 34.000 10.00 240%
2022-03-27 6 42 18 30.250 7.25 317.24%

IMRX Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.

  • Immuneering Corp's upside potential (average analyst target price relative to current price) is higher than 660.8% of all US stocks.
  • In terms of how Immuneering Corp fares relative to all US stocks, note that its variance in analysts' estimates is lower than -244.39% of that group.
  • IMRX has a greater average analyst price target than 535.52% of stocks in the small market cap category.
  • IMRX has a higher number of analysts covering the stock than 240.62% of Healthcare stocks.

In the Pharmaceutical Products industry, IMRA, IMPL, and IMNM are the three stocks most similar to Immuneering Corp regarding the price target and analyst recommendation information presented here.

Make investment decisions regarding IMRX using the data that counts. Try POWR Ratings for free.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!




Page generated in 0.427 seconds.